Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic rhinitis
Scientific Reports · 2024
DOI: 10.1038/s41598-024-54501-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Dehong Mu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China. Hauptthemen laut MEDLINE: Chitosan, Rhinitis, Allergic, Nanoparticles. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Allergic rhinitis (AR) remains a major health problem worldwide. Compared with traditional oral drugs, nasal administration avoids first-pass metabolism and achieve faster and more effective efficacy. In this study, we used the ion crosslinking method to prepare quercetin–chitosan nasal adaptive nanomedicine (QCS) delivery system and evaluated in the treatment of allergic rhinitis mice models. The obtained positively charged nanoparticles with a particle size of 229.2 ± 0.2 nm have excellent characteristics in encapsulation efficiency (79.604%), drug loading rate (14.068%), drug release (673.068 μg) and stability(> 7 days). Excitingly, QCS treatment significantly reduced the number of sneezing and nasal rubbing events in AR mice, while reducing the levels of inflammatory factors such as immunoglobulin E (IgE), interleukin (IL)-17, tumor necrosis factor (TNF)-α, and (IL)-6 to alleviate AR symptoms. Hematoxylin–eosin (HE) staining also showed the damaged nasal mucosa was improved. These experimental results suggest that QCS can effectively suppress allergic inflammation in a mouse model and hold promise as a therapeutic option for allergic rhinitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
- Department of Nanchong Vocational College of Science and Technology, Nanchong, 637200, People's Republic of China.
- Department of Clinical Medicine School of Chengdu, University of Traditional Chinese Medicine, Chengdu, 610075, People's Republic of China.
- Department of Otorhinolaryngology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China. xiongpeizheng@cdutcm.edu.cn.
- Department of Otorhinolaryngology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China. 18980880129@qq.com.
Förderung
- Chengdu University of Traditional Chinese Medicine
Zitieren
APA
Mu, D., Zhou, L., Shi, L., Liu, T., Guo, Y., Chen, H., Luo, H., Ma, J., Zhang, H., Xiong, P., & Tian, L. (2024). Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic rhinitis. Scientific Reports. https://doi.org/10.1038/s41598-024-54501-2
Vancouver
Mu D, Zhou L, Shi L, Liu T, Guo Y, Chen H, et al. Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic rhinitis. Scientific Reports. 2024. doi:10.1038/s41598-024-54501-2
BibTeX
@article{Mu2024,
author = {Mu, Dehong and Zhou, Li and Shi, Lingyu and Liu, Ting and Guo, Ying and Chen, Hao and Luo, Hongping and Ma, Junhao and Zhang, Hui and Xiong, Peizheng and Tian, Li},
title = {Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic rhinitis},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-54501-2}
}
EUVIMED